At Heidelberg Epignostix, our mission is to revolutionize tumor classification by harnessing the power of methylation-based models. By combining cutting-edge technology, advanced computational methods, and our team’s deep expertise, we aim to provide precise and reliable solutions for tumour classification, which may ultimately lead to improved diagnosis, prognosis, and treatment decisions.